162 related articles for article (PubMed ID: 32420748)
1. Apatinib Combined With Radiotherapy Enhances Antitumor Effects in an In Vivo Nasopharyngeal Carcinoma Model.
Liu S; Wu F; Zhang Y; Qin R; Zhu N; Li Y; Wang M; Zeng Q; Xie D; Li Y; Fan J; Han Y
Cancer Control; 2020; 27(1):1073274820922553. PubMed ID: 32420748
[TBL] [Abstract][Full Text] [Related]
2. [The inhibition effects of apatinib on cell proliferation, migration and apoptosis in esophageal carcinoma via Ras/Raf/MEK/ERK and JAK2/STAT3 pathways].
Feng Y; Zhou MY; Sun F; Kong Z; Wang J; Sun ZQ; Hu LJ; Wang JL; Hua Q; Yu JP
Zhonghua Zhong Liu Za Zhi; 2019 Apr; 41(4):263-275. PubMed ID: 31014051
[No Abstract] [Full Text] [Related]
3. Apatinib inhibits VEGFR-2 and angiogenesis in an
Peng QX; Han YW; Zhang YL; Hu J; Fan J; Fu SZ; Xu S; Wan Q
Oncotarget; 2017 Aug; 8(32):52813-52822. PubMed ID: 28881773
[TBL] [Abstract][Full Text] [Related]
4. Apatinib enhances antitumour activity of EGFR-TKIs in non-small cell lung cancer with EGFR-TKI resistance.
Li F; Zhu T; Cao B; Wang J; Liang L
Eur J Cancer; 2017 Oct; 84():184-192. PubMed ID: 28822888
[TBL] [Abstract][Full Text] [Related]
5. Combination of pigment epithelium-derived factor with radiotherapy enhances the antitumor effects on nasopharyngeal carcinoma by downregulating vascular endothelial growth factor expression and angiogenesis.
Xu Z; Fang S; Zuo Y; Zhang Y; Cheng R; Wang Q; Yang Z; Cai W; Ma J; Yang X; Gao G
Cancer Sci; 2011 Oct; 102(10):1789-98. PubMed ID: 21707863
[TBL] [Abstract][Full Text] [Related]
6. Autocrine VEGF signaling promotes cell proliferation through a PLC-dependent pathway and modulates Apatinib treatment efficacy in gastric cancer.
Lin Y; Zhai E; Liao B; Xu L; Zhang X; Peng S; He Y; Cai S; Zeng Z; Chen M
Oncotarget; 2017 Feb; 8(7):11990-12002. PubMed ID: 28061477
[TBL] [Abstract][Full Text] [Related]
7. Enhanced therapeutic efficacy of adenovirus-mediated interleukin-24 gene therapy combined with ionizing radiotherapy for nasopharyngeal carcinoma.
Liu J; Zhang Y; Sun P; Xie Y; Xiang J; Yang J
Oncol Rep; 2013 Sep; 30(3):1165-74. PubMed ID: 23783436
[TBL] [Abstract][Full Text] [Related]
8. In vitro and in vivo apatinib inhibits vasculogenic mimicry in melanoma MUM-2B cells.
Liu ZJ; Zhou YJ; Ding RL; Xie F; Fu SZ; Wu JB; Yang LL; Wen QL
PLoS One; 2018; 13(7):e0200845. PubMed ID: 30052652
[TBL] [Abstract][Full Text] [Related]
9. Apatinib monotherapy for advanced VEGFR-2-negative nasopharyngeal carcinoma: A case report.
Jin J; Du J; Wu Y
Medicine (Baltimore); 2019 Jan; 98(1):e13491. PubMed ID: 30608382
[TBL] [Abstract][Full Text] [Related]
10. Apatinib inhibits VEGF signaling and promotes apoptosis in intrahepatic cholangiocarcinoma.
Peng H; Zhang Q; Li J; Zhang N; Hua Y; Xu L; Deng Y; Lai J; Peng Z; Peng B; Chen M; Peng S; Kuang M
Oncotarget; 2016 Mar; 7(13):17220-9. PubMed ID: 26967384
[TBL] [Abstract][Full Text] [Related]
11. Apatinib, an Inhibitor of Vascular Endothelial Growth Factor Receptor 2, Suppresses Pathologic Ocular Neovascularization in Mice.
Kim KL; Suh W
Invest Ophthalmol Vis Sci; 2017 Jul; 58(9):3592-3599. PubMed ID: 28715845
[TBL] [Abstract][Full Text] [Related]
12. Apatinib Combined with Local Irradiation Leads to Systemic Tumor Control via Reversal of Immunosuppressive Tumor Microenvironment in Lung Cancer.
Liang LJ; Hu CX; Wen YX; Geng XW; Chen T; Gu GQ; Wang L; Xia YY; Liu Y; Fei JY; Dong J; Zhao FH; Ahongjiang Y; Hui KY; Jiang XD
Cancer Res Treat; 2020 Apr; 52(2):406-418. PubMed ID: 31476848
[TBL] [Abstract][Full Text] [Related]
13. The effect of apatinib combined with chemotherapy or targeted therapy on non-small cell lung cancer in vitro and vivo.
Liu M; Wang X; Li H; Xu L; Jing L; Jiang P; Liu B; Li Y
Thorac Cancer; 2019 Oct; 10(10):1868-1878. PubMed ID: 31486270
[TBL] [Abstract][Full Text] [Related]
14. Triptolide Combined with Radiotherapy for the Treatment of Nasopharyngeal Carcinoma via NF-κB-Related Mechanism.
Zhang W; Kang M; Zhang T; Li B; Liao X; Wang R
Int J Mol Sci; 2016 Dec; 17(12):. PubMed ID: 27999372
[TBL] [Abstract][Full Text] [Related]
15. Apatinib exerts anti-tumor activity to non-Hodgkin lymphoma by inhibition of the Ras pathway.
Wang Y; Deng M; Chen Q; Li Y; Guo X; Shi P; He L; Xie S; Yu L; Zhang H; Xu B
Eur J Pharmacol; 2019 Jan; 843():145-153. PubMed ID: 30423319
[TBL] [Abstract][Full Text] [Related]
16. Apatinib potentiates irradiation effect via suppressing PI3K/AKT signaling pathway in hepatocellular carcinoma.
Liao J; Jin H; Li S; Xu L; Peng Z; Wei G; Long J; Guo Y; Kuang M; Zhou Q; Peng S
J Exp Clin Cancer Res; 2019 Nov; 38(1):454. PubMed ID: 31694662
[TBL] [Abstract][Full Text] [Related]
17. Apatinib-loaded nanoparticles inhibit tumor growth and angiogenesis in a model of melanoma.
Zhang J; Liu P; Zhang Z; Han J; Yang X; Wang A; Zhang X
Biochem Biophys Res Commun; 2020 Jan; 521(2):296-302. PubMed ID: 31668370
[TBL] [Abstract][Full Text] [Related]
18. Apatinib inhibits migration and invasion as well as PD-L1 expression in osteosarcoma by targeting STAT3.
Zheng B; Ren T; Huang Y; Guo W
Biochem Biophys Res Commun; 2018 Jan; 495(2):1695-1701. PubMed ID: 29225166
[TBL] [Abstract][Full Text] [Related]
19. Apatinib enhanced anti-tumor activity of cisplatin on triple-negative breast cancer through inhibition of VEGFR-2.
Gao Z; Shi M; Wang Y; Chen J; Ou Y
Pathol Res Pract; 2019 Jul; 215(7):152422. PubMed ID: 31079851
[TBL] [Abstract][Full Text] [Related]
20. [Effect of targeted therapy with cisplatin-loaded magnetic nanoparticles combined with radiotherapy for nasopharyngeal carcinoma in nude mice].
Long Z; Xie MQ; Zhang T; Shen H; Xu XQ; Guo L
Nan Fang Yi Ke Da Xue Xue Bao; 2009 Sep; 29(9):1827-30. PubMed ID: 19778802
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]